Open company graph database — free web & API
Login

FUSHIMI Pharmaceutical Co.,Ltd.

株式会社伏見製薬所
Ticker
—
Listed market
—
Country
Japan
Employees (consolidated)
239
Related companies
8
§01

Basic information

BASIC
Head office
1676 Nakatsu-cho, Marugame City, Kagawa Prefecture, Japan
Chief executive
Shunichi Fushimi
Capital
100,000,000 JPY
Employees (non-consolidated)
Employees (consolidated)
239 people
Start date
1951-04-01
End date
§02

Websites

1 DOMAINS
§03

Business

13
Pharmaceuticals and related productsIndustrial chemicalsChemical productsHigh-performance materialsPrecision chemicalsFunctional cosmetic ingredientsSugar-related productsSanitation inspection centerFoodOthersOrganic synthesis outsourcingSugar researchMedical lubricants
§04

Related companies

8 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Technopores Korea Co., Ltd.
Group Parent
G.I.Lab Inc.
Group Parent
EcoZeri Corporation
Group Parent
Lien Pilote Co., Ltd.
Group
TECHNOPOROUS KOREA CO., LTD.
Group
Fushimi Resin Co., Ltd.
Group
FUSHIMI Pharmaceutical Co.,Ltd.
Group Subsidiary
Magical Converting Co., Ltd.
Group
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

53 EVENTS

President Fushimi Toyo’s grandfather, Toyoji, founded a Kompira dye company in Kinkurakawa-shiri, Kinkurakawa-cho (now Nakatsu-cho), Marugame City. Initially, the company mainly produced 'ammonium nitrate' and 'hydrochloric acid'; 'ammonium nitrate' was supplied to dye manufacturers, while 'hydrochloric acid' was delivered to the Kure Naval Arsenal for military use.Sources

Founded Fushimi Pharmaceutical Plant (Founder: Toyoji Fushimi): Commenced manufacturing and sales of anhydrous ammonium sulfate and sulfide dyes.Sources

The company changed its name to Fushimi Pharmaceutical and began producing barium chloride using barium sulfate, the main component of a barium sulfate crystal obtained from China. Products were packed in 50‑kilogram wooden crates and shipped. They were transported by ox carts or trolleys to a nearby quay, then shipped by boat to Osaka.Sources

Commenced manufacturing and sales of sodium sulfide.Sources

A private Fushimi Pharmaceutical Youth School was opened within the factory to educate employees. The school was established under the 1935 Youth School Ordinance, providing military training‑centered social education for men and women who had graduated from elementary school. It was set up inside the factory to reduce commuting time and align study hours with work hours.Sources

The inaugural general meeting of Fushimi Pharmaceutical Co., Ltd. was held on April 2, marking the start of the new corporate structure. Since its founding in 1923 as a privately owned business, the company transitioned to a corporation in response to changing times and future development.Sources

Reorganized into Fushimi Pharmaceutical Co., Ltd.Sources

Commenced manufacturing and sales of BaSO4 as per the Japanese Pharmacopoeia.Sources

Barium sulfate, a major product now used as an X‑ray contrast agent in medical settings, originated from the company’s own production of barium chloride. Through trial and error, the company developed a formulation that met official standards, producing the 'Baritogen' based on official barium sulfate. Subsequently, the 'dual‑contrast method' revolutionized X‑ray diagnostics, was introduced worldwide through the International Gastroenterological Society, and received high international acclaim. At the same time, the 'gastric collection car' became widespread.Sources

Commenced manufacturing and sales of BaSO4 X-ray contrast agent.Sources

Released "Baritogen".Sources

Established Tokushima factory.Sources

Commenced manufacturing and sales of various ammonium sulfates.Sources

Commenced manufacturing and sales of benzoic acid.Sources

Obtained approval for a factory designated under Japanese Industrial Standards.Sources

Commenced manufacturing and sales of sodium benzoate.Sources

Released "Baritogen-Deluxe" and "Baritogen Zol".Sources

President Toyoji was elected chairman of the Kagawa Prefecture Business Association. Already holding many positions in various institutions and organizations, his external activities expanded further.Sources

Established Fushimi Resin Co., Ltd. as a joint venture with Ube Kogyo Co., Ltd.Sources

Fushimi Pharmaceutical Inc., responsible for the pharmaceutical sales division, was founded. This led to the establishment of sales headquarters and offices in Marugame, Shioya, Tokyo, Osaka, and Tokushima, driving growth. Later, sales offices expanded nationwide to Nagoya, Sendai, Chugoku, and Hakata.Sources

Released "Umbrazol-A".Sources

Separated and independently established the sales division as Fushimi Pharmaceutical Co., Ltd.Sources

Opened a distribution center.Sources

Released "Baritogen Foaming Agent" (currently Baritogen Foaming Internal Liquid 2%).Sources

Released "Baritogen Foaming Granules".Sources

Commencement of manufacturing and sale of benzoic acid esters.Sources

Release of Fushimi, a sodium sulfate product by Nichikoku.Sources

Release of Baritgenzol 120 and Baritgenzol 145.Sources

Commencement of manufacturing of cosmetic Pufuran.Sources

Developed Eco-Jelly, a water supply material for cut flowers.Sources

Release of Baritgen HD.Sources

Completion of Showa Town factory.Sources

Release of Baritgen CT.Sources

Release of Baritgen SHD.Sources

Release of Fast-Run Tablets (currently 2.5 mg).Sources

Obtained ISO 9002 certification (for certain aspects of benzoic acid, sodium benzoate, and organic synthesis).Sources

Completion of the organic synthesis multi-purpose plant (GMP compliant).Sources

Integrated the Industrial Pharmaceutical Sales Department of Fushimi Pharmaceutical Co., Ltd. into Fushimi Pharmaceutical Co., Ltd.Sources

Release of Baritester A240 powder and Enemaster injection powder.Sources

The technical expertise cultivated through the manufacturing of industrial chemicals and pharmaceuticals is being leveraged in the development of new products. By developing the continuous microporous sponge "TechnoPorous", which boasts excellent absorbency and chemical resistance, we can adjust the sponge's hardness and pore size, and enhance functional properties such as conductivity, antibacterial and antifungal resistance, and flame retardancy, resulting in a product that becomes one of the company's pillars.Sources

Obtained ISO 9001 certification transition.Sources

Commencement of manufacturing and overseas sales of Technopores.Sources

Commencement of domestic sales of Technopores.Sources

Commenced sale of rare sugar reagents.Sources

We developed "Rabitol", which has higher flame retardancy than conventional flame retardants and produces fewer harmful gases when burning, offering superior safety. The casings of everyday-used computers and printers, as well as their components and circuit boards, can catch fire, necessitating flame retardancy. Registered in the chemical inventories of major countries worldwide, we are leveraging its excellent stability to expand markets domestically and internationally.Sources

Commenced sale of high-performance phosphazene derivatives (Rabitour® series).Sources

Release of Birease foam granules.Sources

Release of "UmbrMD"Sources

Established G.I.Lab Inc. for remote reading support service businessSources

Established Eco Jelly Inc. as a sales company for Eco Jelly businessSources

Sodium benzoate factory within headquarters factory complies with FSSC22000 standardSources

Established TechnoPorous Korea Inc. in Pocheon, South KoreaSources

Launch of "Colonfort Oral Suspension 25%" for colon CT oral contrast agentSources

§07

News

0 ARTICLES

There is no news.

§08

Public records

GOV
National Tax Agency basic information5470001007604
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
株式会社伏見製薬所
Trade name (kana)
フシミセイヤクショ
Name in English
Corporation type
301
Address
〒763-0054 香川県丸亀市中津町1676番地
Postal code
7630054
Prefecture code
37
City code
202
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2018-07-09
Change date
2015-10-05
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
1
Trade name image ID
Address image ID
Sequence number
5058323
METI gBizINFO5470001007604
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
5470001007604
Trade name
株式会社伏見製薬所
Trade name (kana)
フシミセイヤクショ
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
香川県丸亀市中津町1676番地
Postal code
7630054
Prefecture
香川県
Prefecture code
37
City or district
丸亀市
City code
202
Street address
中津町1676番地
Organisation type
301
Processing type
01
Correction type
1
Status
Representative
Capital
Employees
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2018-07-09
Key information
5470001007604
§09

Sources & updates

SOURCES
↑